Franklin Resources
TBPH icon

Franklin Resources’s Theravance Biopharma TBPH Stock Holding History

Franklin Resources’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
103,260
+6,110
+6% +$101K ﹤0.01% 2057
2026
Q1 		$1.58M Buy
97,150
+6,418
+7% +$114K ﹤0.01% 1995
2025
Q4 		$1.7M Sell
90,732
-1,695
-2% -$28.1K ﹤0.01% 1867
2025
Q3 		$1.35M Buy
92,427
+56,618
+158% +$715K ﹤0.01% 1949
2025
Q2 		$395K Buy
35,809
+11
+0% +$107 ﹤0.01% 2434
2025
Q1 		$320K Buy
35,798
+24,323
+212% +$226K ﹤0.01% 2456
2024
Q4 		$108K Buy
11,475
+464
+4% +$4.22K ﹤0.01% 2748
2024
Q3 		$90.6K Sell
11,011
-1,736
-14% -$15K ﹤0.01% 2752
2024
Q2 		$108K Sell
12,747
-210
-2% -$1.9K ﹤0.01% 2669
2024
Q1 		$116K Sell
12,957
-11
-0.1% -$102 ﹤0.01% 2687
2023
Q4 		$146K Buy
+12,968
New +$131K ﹤0.01% 2416
2023
Q3 		– Sell
-41,915
Closed -$434K – 2780
2023
Q2 		$434K Buy
41,915
+30,503
+267% +$337K ﹤0.01% 2031
2023
Q1 		$124K Sell
11,412
-3,788
-25% -$40.1K ﹤0.01% 2080
2022
Q4 		$171K Buy
15,200
+3,832
+34% +$40.3K ﹤0.01% 2033
2022
Q3 		$115K Buy
11,368
+119
+1% +$1.11K ﹤0.01% 2084
2022
Q2 		$102K Sell
11,249
-5,011
-31% -$46.2K ﹤0.01% 2148
2022
Q1 		$155K Buy
+16,260
New +$159K ﹤0.01% 2223
2017
Q1 		– Sell
-379,400
Closed -$12.1M – 1516
2016
Q4 		$12.1M Buy
+379,400
New +$11.8M 0.01% 913

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Franklin Resources's TBPH Position: Q2 2026 in Review

Franklin Resources increased its Theravance Biopharma (TBPH) stake by 6.3% in Q2 2026, buying an estimated $101K and bringing the position to 103,260 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Franklin Resources first reported a position in TBPH in Q4 2016 and has held it in 18 quarters since. The position peaked at $12.1M in Q4 2016. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Franklin Resources held 103,260 shares of Theravance Biopharma worth $1.76M as of Q2 2026.
  • Franklin Resources bought 6,110 Theravance Biopharma shares in Q2 2026, an estimated $101K.
  • Theravance Biopharma made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2057 holding.
  • Franklin Resources first reported a position in Theravance Biopharma in Q4 2016 and has held it in 18 quarters since.
  • Franklin Resources's Theravance Biopharma position peaked at $12.1M in Q4 2016.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.